Making science matter: A vision for a new century of life-changing science: Peter Schultz, PhD
January 10, 2024
In the inaugural lecture of the 2024 Centennial Front Row series, President and CEO Peter Schultz will illuminate how Scripps Research is building on its storied past—a remarkable century of discovery and innovation—to establish a new paradigm for the future of science and medicine. Under Schultz’s leadership, Scripps Research is expanding its global impact by empowering exceptional scientists to pursue groundbreaking ideas and seamlessly blending curiosity-fueled science with impact-driven drug discovery. Schultz shared how this unique approach is already giving rise to a new generation of first-in-class medicines against cancers, heart disease, deadly pathogens, neurological disorders, and many other health threats.
How experiences shape the developing brain and impact neurological diseases
February 21, 2024
As we age, learn and grow over our lifetimes, the brain continually responds and adapts to what we experience. In this Front Row lecture, Scripps Research Chair of the Department of Neuroscience Hollis Cline revealed how sensory experiences shape the brain during development and aging—particularly visual experiences. Cline’s work has been critical in revealing how key visual brain circuits become disrupted in neurodevelopmental disorders, as well as in mapping the different communication pathways between neurons.
Bringing precision therapy to mental disorders: Hugh Rosen, MD, PhD
March 20, 2024
Mental disorders like depression and schizophrenia affect the lives of millions of people around the world, and yet, available treatment options have remained the same for decades. In this free Front Row lecture, Scripps Research professor Hugh Rosen shared how his pioneering research led to the development of the drug navacaprant, which precisely targets one of the brain’s behavioral circuits and is currently in clinical testing for major depressive disorder. Harnessing his expertise as a physician-scientist, Rosen has discovered and developed multiple other medicines, including ozanimod—a breakthrough treatment approved for multiple sclerosis and ulcerative colitis.